Follicular lymphoma natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:
{{CMG}}; {{AE}} {{AS}}
{{CMG}}; {{AE}} {{AS}}
==Overview==
==Overview==
Follicular lymphoma presents in the age group of 60-65 with systemic symptoms of fever, weight loss, anorexia, night sweats and other organ dependent symptoms based on the metastatic spread of the lymphoma. Complications arise from the systemic effects of the lympoma and metastasis. The prognosis is evaluated from follicular lymphoma international prognostic index which divides patients into 3 groups.
Follicular lymphoma presents in the age group of 60-65 with systemic symptoms of [[fever]], [[weight loss]], [[anorexia]], [[night sweats]] and other organ dependent symptoms based on the [[Metastasis|metastatic]] spread of the lymphoma. Complications arise from the systemic effects of the lymphoma and metastasis. The prognosis is evaluated from follicular lymphoma international prognostic index which divides patients into 3 groups.


== Natural history ==
== Natural history ==
Line 10: Line 10:
* Patients may present with complaints of:
* Patients may present with complaints of:
** Unexplained fever
** Unexplained fever
** Weight loss
** [[Weight loss]]
** Painless and progressive adenopathy
** Painless and progressive [[adenopathy]]
** Night sweats
** Night sweats
** Gastric symptoms
** Gastric symptoms
Line 23: Line 23:
* Organ related symptoms develop depending on the metastatic spread of the lymphoma.
* Organ related symptoms develop depending on the metastatic spread of the lymphoma.
* Patients may have a history of:
* Patients may have a history of:
** Viral disease (HIV, HBV, HCV or EBV)
** Viral disease ([[Human Immunodeficiency Virus (HIV)|HIV]], [[Hepatitis B virus|HBV]], [[Hepatitis C|HCV]] or [[Epstein Barr virus|EBV]])
** Autoimmune diseases
** [[Autoimmune diseases]]
** Immunocompromised state
** [[Immunodeficiency|Immunocompromised]] state


== Complications ==
== Complications ==
* Skin reactions
* Skin reactions
* Bone marrow suppresion
* [[Bone marrow]] suppresion
* Second cancers
* Second cancers
* Gasrric obstruction
* Gastric obstruction
* Urethral obstruction
* Urethral obstruction
* Renal failure
* [[Renal insufficiency|Renal failure]]
* Infertility
* [[Infertility]]
* Heart problems (Heart failure, vavular defects, pericarditis)
* Heart problems (Heart failure, vavular defects, pericarditis)
* Lung problems (Pleural effusion, lung mass)
* Lung problems (Pleural effusion, lung mass)

Revision as of 22:50, 27 December 2018

Follicular lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Follicular lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT scan

MRI

Echocardiography or Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Follicular lymphoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Follicular lymphoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Follicular lymphoma natural history, complications and prognosis

CDC on Follicular lymphoma natural history, complications and prognosis

Follicular lymphoma natural history, complications and prognosis in the news

Blogs on Follicular lymphoma natural history, complications and prognosis

Directions to Hospitals Treating Follicular lymphoma

Risk calculators and risk factors for Follicular lymphoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Follicular lymphoma presents in the age group of 60-65 with systemic symptoms of fever, weight loss, anorexia, night sweats and other organ dependent symptoms based on the metastatic spread of the lymphoma. Complications arise from the systemic effects of the lymphoma and metastasis. The prognosis is evaluated from follicular lymphoma international prognostic index which divides patients into 3 groups.

Natural history

Complications

  • Skin reactions
  • Bone marrow suppresion
  • Second cancers
  • Gastric obstruction
  • Urethral obstruction
  • Renal failure
  • Infertility
  • Heart problems (Heart failure, vavular defects, pericarditis)
  • Lung problems (Pleural effusion, lung mass)
  • Mediastinal mass
  • Immune system deficiency

Prognosis

  • Follicular Lymphoma International Prognostic Index (FLIPI) is used for the evaluation of prognosis[5][6].
  • It includes the following:
    • age >60 years
    • bone marrow involvement
    • hemoglobin level <12.0 g/dl
    • greatest diameter of the largest involved node >6 cm
    • elevated serum β-2 microglobulin level
  • The FLIPI divides pateints into 3 groups:
    • Low (0-1 risk factor)
    • Intermediate (2 risk factors)
    • High (≥ 3 risk factors)
  • The 10 year mortality of low group is 96%.
  • The 10 year mortality of intermediate group is 71%.
  • The 10 year mortality of high group is 37%.

References

  1. Kridel R, Sehn LH, Gascoyne RD (2012). "Pathogenesis of follicular lymphoma". J Clin Invest. 122 (10): 3424–31. doi:10.1172/JCI63186. PMC 3461914. PMID 23023713.
  2. "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project". Blood. 89 (11): 3909–18. 1997. PMID 9166827.
  3. Winberg CD, Nathwani BN, Bearman RM, Rappaport H (1981). "Follicular (nodular) lymphoma during the first two decades of life: a clinicopathologic study of 12 patients". Cancer. 48 (10): 2223–35. PMID 7028244.
  4. Fernández de Larrea C, Martínez-Pozo A, Mercadal S, García A, Gutierrez-García G, Valera A; et al. (2011). "Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma". Br J Haematol. 153 (3): 334–40. doi:10.1111/j.1365-2141.2011.08596.x. PMID 21375524.
  5. Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R; et al. (2004). "Follicular lymphoma international prognostic index". Blood. 104 (5): 1258–65. doi:10.1182/blood-2003-12-4434. PMID 15126323.
  6. Martin AR, Weisenburger DD, Chan WC, Ruby EI, Anderson JR, Vose JM; et al. (1995). "Prognostic value of cellular proliferation and histologic grade in follicular lymphoma". Blood. 85 (12): 3671–8. PMID 7780151.